BNR Stock Analysis: Buy, Sell, or Hold?
BNR - Burning Rock Biotech Limited American Depositary Shares
$34.06
0.52 (1.55%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Dec 02, 2025
0d
Get Alerted When BNR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BNR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BNR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BNR is currently trading at $34.06, which is considered extended relative to its 30-day fair value range of $20.80 to $33.56.
Technical Outlook: Technically, BNR is in a strong uptrend. Immediate support is located at $29.67, while resistance sits at $41.72.
Market Sentiment: BNR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $4.03. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BNR is in a strong uptrend. Immediate support is located at $29.67, while resistance sits at $41.72.
Market Sentiment: BNR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $4.03. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$20.80 -
$33.56
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding BNR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 88.0% above Wall St target ($4.03)
Fair Price Analysis
30-Day Fair Range
$20.80 -
$33.56
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$29.67
Resistance Level
$41.72
Current Trend
Strong Uptrend
Fundamental Context
Wall Street Target
$4.03
(-88.0%)
Revenue Growth (YoY)
2.3%
Profit Margin
-22.5%
Last updated: January 30, 2026 5:51 PM ET
Data refreshes hourly during market hours. Next update: 6:51 PM
Data refreshes hourly during market hours. Next update: 6:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
Advanced BNR Option Strategies
Professional options setups generated by AI based on today's BNR price and gamma walls.
